Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Tylenol Recalled Due To Higher Levels of Chlorpheniramine Ammonio Acetate

By Pharmaceutical Processing | August 16, 2011

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. (McNeil) is
voluntarily recalling, at the retail and wholesale level, certain lots
of products containing TYLENOL® Cold Multi-Symptom Nighttime Rapid
Release Gelcaps distributed in the United States and Puerto Rico. This
is not a consumer level recall and the risk of any adverse health
effects related to the reason for the recall is unlikely.

McNeil is initiating the recall as a precaution after
determining, through monitoring of product samples, that the level of a
compound contained in the product, known as Chlorpheniramine Ammonio
Acetate (CPAA), was slightly higher than expected in some TYLENOL® Cold
Multi-Symptom Nighttime Rapid Release Gelcaps. CPAA is a compound
formed from the combination of two product ingredients and certain
levels are expected in the product.

No safety concerns have been associated with CPAA and it is
unlikely to cause an adverse reaction. This action is not being
undertaken on the basis of adverse events. No action is required by
consumers or healthcare providers and consumers can continue to use the
product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

The lot numbers (full product list attached below) for the
recalled product can be found on the side of the carton label. Consumers
with general questions should call our Consumer Care Center at
1-888-222-6036 (available Monday-Friday 8 a.m. to 8 p.m. Eastern Time).
Consumers who have health concerns should contact their healthcare
provider.

FULL RECALLED PRODUCT LIST:

Product Name

Lot Number

UPC Code

TYLENOL® COLD MULTI-SYMPTOM NIGHTTIME RAPID RELEASE GELS 24 RR GELCAPS

AMA277, APA059, APA162, ASA025, APA237, ASA072, ASA208, BAA008

300450395245

TYLENOL® COLD MULTI-SYMPTOM RAPID RELEASE GELS DAY/NIGHT 12+8 RR GELCAPS

AMF034, BAF005, BAF027, BCF080

300450396204

TYLENOL® COLD MULTI-SYMPTOM RAPID RELEASE GELS DAY/NIGHT 36+24 RR GELCAPS

BBF001, BCF060, BCF079

300450396600

 

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE